ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    One Year Results of the Effects of Rituximab on Acute Humoral Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Randomized Placebo Controlled Trial

    B. Sautenet, G. Blancho, M. Buchler, E. Morelon, O. Toupance, B. Barrou, D. Ducloux, B. Hurault de Ligny, B. Moulin, A. Le Gouge, Y. Lebranchu

    Nephrology, CHRU Bretonneau, Tours, France; CIC INSERM 202, CHRU Bretonneau, Tours, France; Nephrology, CHRU, Nantes, France; Nephrology, CHRU Edouard Herriot, Lyon, France; Nephrology, CHRU Maison Blanche, Reims, France; Urology, CHRU Pitie Salpetriere, Paris, France; Nephrology, CHRU Saint Jacques, Besançon, France; Nephrology, CHRU, Caen, France; Nephrology, CHRU Civil, Strasbourg, France

    Background: The treatment of acute humoral rejection (AHR) is currently based on the combination of plasmepheresis (PE), intravenous immune globulin (IVIg) and corticosteroids (CS). Patients…
  • 2013 American Transplant Congress

    Risk Factors for Early Onset of Acute Kidney Injury and Subsequent Development of Chronic Renal Disease after Liver Transplantation

    D. Tomescu, M. Popescu, G. Droc, S. Dima, I. Popescu

    Anesthesia and Intensive Care, Fundeni Clinical Institute, Bucharest, Romania; Center of General Surgery and Liver Transplantation, Fundeni Clinical Insitute, Bucharest, Romania

    Background. Renal impairement is one of the most common complications following liver transplantation (LT) and it is associated with an increased length of stay in…
  • 2013 American Transplant Congress

    mTOR, but Not Calcineurin, Inhibition Safeguards Anti-Tumoral CD8 Immunity in Transplant Recipients

    J. Rovira, M. Sabet-Baktach, M. Lantow, E. Eggenhofer, G. Koehl, H. Schlitt, J. Campistol, E. Geissler, A. Kroemer

    Department of Surgery, University Hospital Regensburg, Regensburg, Germany; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain

    The purpose of this study was to investigate the role of mTOR versus calcineurin inhibition in anti-tumoral CD8+ T cell responses in posttransplant malignancy. To…
  • 2013 American Transplant Congress

    Microcirculation Inflammation Is Superior to Peritubular Capillary Basement Membrane Multilayering for Outcome Prediction in Renal Transplant Patients with De Novo Donor-Specific Antibodies

    H. de Kort, M. Willicombe, P. Brookes, L. Moran, E. Santos-Nunez, J. Galliford, D. Taube, A. McLean, J. Moss, H. Cook, C. Roufosse

    Imperial College NHS Trust, London, United Kingdom; , United Kingdom

    In renal transplant patients with de novo donor-specific antibodies (DSA) we compared peritubular capillary basement membrane multilayering (PTCBML) counts with microcirculation inflammation (MI) score to…
  • 2013 American Transplant Congress

    Acute Rejection on Surveillance Biopsies Is a Predictor of Functional Decline in Kidney Transplants over Long-Term Follow-Up

    A. Desai, N. Nader, J. Brar, S. Patel, M. Laftavi, R. Venuto, M. Zachariah

    Nephrology and Transplantation, SUNY at Buffalo, Buffalo, NY; Anesthesiology, VA Medical Center and SUNY at Buffalo, Buffalo, NY

    Background: Identifying specific factors that are predictive of renal allograft functional decline is important toward prolonging graft survival. Few studies have addressed specific histologic diagnoses…
  • 2013 American Transplant Congress

    Epigenetic Mechanisms Underlying Allograft Rejection: Role of the Histone Acetyltransferase, GCN-5 in T Cell Activation, Proliferation and Cytokine Production

    C. Bao, Y. Liu, L. Wang, R. Han, S. Dent, W. Hancock

    Cardiothoracic Surgery, Shanghai Jiaotong University School of Medicine, Shanghai, China; Path & Lab Med, CHOP/UPenn, Philadelphia; Carcinogenesis, MD Anderson Cancer Center, Houston

    There is currently no literature on the roles of histone acetyltransferases (HATs) in allograft biology, despite the central roles that these enzymes are thought to…
  • 2013 American Transplant Congress

    Intragraft Gene Expression Profiles of C4d-/DSA+ and C4d-/DSA- Transplant Glomerulopathy Biopsies Compared to Biopsies with Chronic Antibody Mediated Rejection

    N. Hayde, Y. Bao, J. Pullman, G. De Boccardo, M. Lubetzky, E. Akalin

    Montefiore/Einstein Transplant Center, Bronx, NY

    Background: We investigated the histopathologic features and gene expression profiles of C4d-/donor-specific anti-HLA antibodies (DSA)+ and C4d-/DSA- transplant glomerulopathy (TGP) biopsies compared to C4d+/DSA+ chronic…
  • 2013 American Transplant Congress

    Decade of Experience with Deceased Donor Kidney Transplantation in Recipients over Age 75, A

    U. Farooq, A. Farney, J. Rogers, G. Orlando, Y. Al-Shraideh, R. Stratta

    Abdominal Transplant, General Surgery, Wake Forest Baptist Medical Center, Winston Salem, NC

    We retrospectively reviewed outcomes in adult patients (pts) 75 years receiving deceased donor kidney transplants (KTs) at our center. Results: We performed 46 KTs in…
  • 2013 American Transplant Congress

    Anti-ER-TR7 mAb Prevents Tolerogenic Lymph Node Morphogenesis and Overrides Transplant Tolerance

    B. Burrell, J. Bromberg

    University of Maryland, Baltimore

    Background: Transplant tolerance is exquisitely sensitive to changes in secondary lymphoid organ structure and function. Costimulatory blockade plus donor-specific splenocyte transfusion (DST) induces long-term graft…
  • 2013 American Transplant Congress

    Problems and Pitfalls in Calculation of “True” Treg Numbers Using Assays of Foxp3 TSDR Demethylation in PBMC of Transplant Recipients

    T. Akimova, B. Kamath, J. Goebel, K. Meyers, E. Rand, M. Levine, J. Bucuvalas, W. Hancock

    CHOP/UPenn, Philadelphia; Hospital for Sick Children, Toronto, Canada; Cincinnati Children's Hospital, Cincinnati

    FOXP3 is the master transcription factor of CD4+CD25+FOXP3+ T-regulatory (Treg) cells, and demethylation of the Treg-specific demethylation region (TSDR) of FOXP3 is considered a specific…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences